1,710 Shares in Oracle Co. (NYSE:ORCL) Purchased by KWB Wealth

KWB Wealth bought a new position in shares of Oracle Co. (NYSE:ORCLFree Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,710 shares of the enterprise software provider’s stock, valued at approximately $215,000.

Several other institutional investors have also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of Oracle in the 4th quarter worth approximately $1,210,181,000. Wellington Management Group LLP boosted its holdings in Oracle by 9,299.3% in the third quarter. Wellington Management Group LLP now owns 8,170,999 shares of the enterprise software provider’s stock worth $865,472,000 after acquiring an additional 8,084,067 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Oracle by 5.7% during the third quarter. Vanguard Group Inc. now owns 147,273,413 shares of the enterprise software provider’s stock valued at $15,599,200,000 after acquiring an additional 7,883,515 shares in the last quarter. Boston Partners raised its position in shares of Oracle by 382.4% in the 4th quarter. Boston Partners now owns 4,563,366 shares of the enterprise software provider’s stock worth $481,820,000 after purchasing an additional 3,617,413 shares during the last quarter. Finally, Capital World Investors boosted its stake in Oracle by 22.1% in the 4th quarter. Capital World Investors now owns 18,384,162 shares of the enterprise software provider’s stock worth $1,938,242,000 after purchasing an additional 3,323,334 shares in the last quarter. Institutional investors own 42.44% of the company’s stock.

Oracle Trading Up 0.9 %

Shares of ORCL stock traded up $1.27 during trading hours on Friday, reaching $145.65. 856,577 shares of the stock were exchanged, compared to its average volume of 8,581,018. The firm has a market capitalization of $401.39 billion, a price-to-earnings ratio of 38.92, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. Oracle Co. has a 12-month low of $99.26 and a 12-month high of $145.73. The company’s 50-day moving average price is $127.54 and its 200-day moving average price is $119.13. The company has a current ratio of 0.71, a quick ratio of 0.72 and a debt-to-equity ratio of 8.25.

Oracle (NYSE:ORCLGet Free Report) last released its earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 EPS for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.02). The business had revenue of $14.29 billion for the quarter, compared to the consensus estimate of $14.57 billion. Oracle had a net margin of 19.76% and a return on equity of 223.01%. The company’s quarterly revenue was up 3.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.35 EPS. As a group, equities analysts anticipate that Oracle Co. will post 5.01 earnings per share for the current year.

Oracle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 25th. Investors of record on Thursday, July 11th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.10%. The ex-dividend date of this dividend is Thursday, July 11th. Oracle’s dividend payout ratio is presently 43.13%.

Wall Street Analyst Weigh In

Several brokerages recently commented on ORCL. UBS Group increased their price objective on shares of Oracle from $150.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, June 12th. Mizuho raised their price objective on shares of Oracle from $160.00 to $170.00 and gave the stock a “buy” rating in a report on Monday, June 17th. Morgan Stanley reiterated an “equal weight” rating and issued a $125.00 price target on shares of Oracle in a research report on Tuesday, June 25th. The Goldman Sachs Group boosted their price objective on shares of Oracle from $115.00 to $130.00 and gave the company a “neutral” rating in a research report on Wednesday, March 13th. Finally, Argus raised their target price on Oracle from $145.00 to $159.00 and gave the stock a “buy” rating in a report on Tuesday, June 18th. Fourteen equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $145.83.

Check Out Our Latest Analysis on ORCL

Insider Activity at Oracle

In related news, Director George H. Conrades sold 20,000 shares of the stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $116.00, for a total value of $2,320,000.00. Following the transaction, the director now owns 17,836 shares of the company’s stock, valued at $2,068,976. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, insider Edward Screven sold 235,918 shares of the company’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $144.30, for a total value of $34,042,967.40. Following the completion of the sale, the insider now owns 2,626,764 shares of the company’s stock, valued at approximately $379,042,045.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director George H. Conrades sold 20,000 shares of the company’s stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $116.00, for a total value of $2,320,000.00. Following the sale, the director now owns 17,836 shares of the company’s stock, valued at approximately $2,068,976. The disclosure for this sale can be found here. Insiders sold 385,639 shares of company stock worth $53,002,729 in the last 90 days. 42.80% of the stock is owned by corporate insiders.

Oracle Company Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Further Reading

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.